文献速递心力衰竭与心肌病

印度尼西亚心衰住院患者的多病负担与住院结局回顾性队列研究

Multimorbidity burden and hospitalisation outcomes in heart failure: a retrospective cohort study using Indonesian national health insurance claims data (2019-2024)
RSS 订阅 · Open Heart

该研究利用印度尼西亚国家医保索赔数据(2019–2024 年),纳入 9018 例以心衰为主要诊断的住院成人患者。结果显示多病共存患病率为 72.4%,每增加一种合并症与住院时间延长、30 天及 90 天心衰再入院风险升高相关。不同合并症与不同结局存在差异化关联。

要点

  • 心衰住院患者中多病共存比例高达 72.4%。
  • 每增加一种合并症,住院时间延长 0.13 天,再入院风险增加 22%–27%。
  • 贫血与住院时间延长最相关,缺血性心脏病、慢性肾病、慢阻肺及瓣膜病与再入院相关。

核心结论

  • 印度尼西亚心衰住院患者多病共存高度普遍,且与不良住院结局相关。
  • 多病负担和特定合并症均与住院时间延长及再入院相关。

研究设计与样本

  • 基于人群的回顾性队列研究,使用印度尼西亚国家健康保险计划(Badan Penyelenggara Jaminan Sosial Kesehatan)2019–2024 年的概率加权行政索赔数据。
  • 从所有可用索赔中确定 12 种预先指定的合并症,多病共存定义为心衰之外的合并症数量。

主要发现

  • 多病共存(心衰之外至少一种合并症)的患病率为 72.4%。
  • 每增加一种合并症,住院时间延长 β 0.13 天(95% CI 0.03 至 0.22)。
  • 每增加一种合并症,30 天心衰再入院比值比 OR 1.22(95% CI 1.07 至 1.38),90 天再入院 OR 1.27(95% CI 1.14 至 1.42)。
  • 贫血与住院时间延长的关联最强;缺血性心脏病、慢性肾病、慢性阻塞性肺疾病和瓣膜病与再入院相关。

关键数值与推荐

  • 多病共存患病率为 72.4%。
  • 每增加一种合并症的住院时间延长系数为 β 0.13 天(95% CI 0.03 至 0.22)。
  • 每增加一种合并症的 30 天再入院 OR 为 1.22(95% CI 1.07 至 1.38),90 天再入院 OR 为 1.27(95% CI 1.14 至 1.42)。

临床怎么用

  • 对心衰住院患者应系统评估合并症负担。
  • 贫血、缺血性心脏病、慢性肾病、慢阻肺和瓣膜病的识别可能有助于个体化住院管理。
  • 卫生系统需要更好地兼顾多病共存情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background The expansion of universal health coverage (UHC) in many low- and middle-income countries (LMICs) has occurred alongside a growing burden of chronic disease and multimorbidity. Heart failure (HF) frequently coexists with multimorbidity, which is associated with worse hospitalisation outcomes. However, most evidence on multimorbidity and HF hospitalisation outcomes originates from older populations in high-income countries and nationally representative evidence from LMIC settings remains limited. We aimed to characterise multimorbidity burden among patients hospitalised with HF, evaluate associations with length of stay (LOS) and readmission and identify individual comorbidities associated with these outcomes. Methods We conducted a population-based retrospective cohort study using nationally representative, probability-weighted administrative claims from Badan Penyelenggara Jaminan Sosial Kesehatan, Indonesia’s national health insurance programme (2019–2024). Adults (≥18 years) hospitalised with HF as the primary diagnosis were included. 12 prespecified comorbidities were ascertained from all available claims. Multimorbidity was defined as the number of comorbidities beyond HF. Outcomes were LOS and 30-day and 90-day HF-specific readmissions, analysed using survey-weighted linear and logistic regression adjusted for age and sex. Results Among 9018 patients contributing 12 461 HF episodes (mean age 59.8±13.1 years; 51.4% male), multimorbidity was present in 72.4%. Each additional comorbidity was associated with longer LOS (β 0.13 days; 95% CI 0.03 to 0.22), higher 30-day readmission odds (OR 1.22; 95% CI 1.07 to 1.38) and higher 90-day readmission odds (OR 1.27; 95% CI 1.14 to 1.42). Distinct comorbidity patterns were observed across outcomes: anaemia showed the strongest association with prolonged LOS, whereas ischaemic heart disease, chronic kidney disease, chronic obstructive pulmonary disease and valvular disease were associated with readmission. Conclusions Multimorbidity is highly prevalent among patients hospitalised with HF in Indonesia and is associated with adverse hospitalisation outcomes. Both multimorbidity burden and specific comorbidities were associated with these outcomes, suggesting a need for health systems that better account for multimorbidity.

来源:Open Heart,查看原文。版权归原作者所有。

引用

  1. Open Heart:Multimorbidity burden and hospitalisation outcomes in heart failure: a retrospective cohort study using Indonesian national health insurance claims data (2019-2024)

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。